Anti-inflammatory cannula
View Patent ↗Various embodiments of the present invention include a cannula coated or compounded with a material to extend the wear time for a patient by reducing inflammation and therefore increasing the time that the cannula may remain inserted, thereby increasing the effectiveness of the drug delivered using the cannula. The material may include a hydrophilic material, an anti-microbial material, an anti-inflammatory material, anti-thrombogenic material, or a combination of any of these materials.
1. A wearable fluid delivery device, comprising:
a chamber containing a fluid to be delivered into a body of a patient; and
a cannula in fluid connection with the chamber, the cannula comprising an exterior surface, an inner surface, a lumen and a distal end extending into the patient, wherein the cannula comprises a first material and a second material mixed with the first material, the second material disposed in discrete regions of the cannula, the second material comprising at least one of a hydrophilic material, an anti-microbial material, an anti-inflammatory material, and an anti-thombogenic material, wherein a first coating at least partially covers the exterior surface of the cannula, the first coating comprising an anti-inflammatory agent, wherein a second coating at least partially covers the interior surface of the cannula, the second coating comprising at least one of the hydrophilic material, the anti-microbial material, the anti-inflammatory material, and the anti-thombogenic material,
wherein the second coating covers less than an entire length of the inner surface of the cannula,
wherein the first coating covers less than an entire length of the exterior surface of the cannula,
wherein the second coating coats less than an entire perimeter of the inner surface of the cannula,
wherein the first coating coats less than an entire perimeter of the exterior surface of the cannula,
wherein a third coating at least partially covers the exterior surface of the cannula, the third coating comprising at least one of the hydrophilic material, the anti-microbial material, the anti-inflammatory material, and the anti-thombogenic material, wherein the first and second coatings comprise different materials,
wherein the third coating is disposed in a concentration gradient throughout the first coating.
2. The wearable fluid delivery device of claim 1 , wherein the first material of the cannula comprises a polymeric material.
3. The wearable fluid delivery device of claim 1 , the first coating having a thickness of up to 500 microns.
4. The wearable fluid delivery device of claim 1 , the first coating having a thickness of up to 50 microns.
5. The wearable fluid delivery device of claim 1 , wherein the first coating comprises a material selected from the group consisting of heparin, silver and its alloys, rifampicin, sparfloxacin, triclosan, benalkonium chloride, tridodecylmethylammonium chloride, cefazolin, chitosan, dexamethasone sodium phosphate, polyvinylpyrolidone (PVP), polyurethanes, fluoropolymers, silicone, polyacrylic acid (PAA), polyethylene oxide (PEO), polysaccharides, polyether block amides, and fluorine-acryl-styrene-urethane-silicone (FASUS).
6. The wearable fluid delivery device of claim 5 , wherein the first material of the cannula comprises polyurethane.
7. The wearable fluid delivery device of claim 5 , wherein the first coating comprises a polyether block amide.
8. The wearable fluid delivery device of claim 1 , wherein said second coating comprises an anti-thrombogenic material.
9. The wearable fluid delivery device of claim 8 , wherein said second coating comprises a fluorinated ethylene propylene.
10. The wearable fluid delivery device of claim 1 , wherein the cannula comprises a single unitary body.
11. The wearable fluid delivery device of claim 1 , wherein a fourth coating at least partially covers the inner surface of the cannula, the fourth coating comprising at least one of a hydrophilic material, an anti-microbial material, an anti-inflammatory material, and an anti-thombogenic material, the second and fourth coatings comprising different materials.
12. The wearable fluid delivery device of claim 11 , wherein the second and fourth coatings are mixed homogeneously.
13. The wearable fluid delivery device of claim 11 , wherein the fourth coating is disposed in discrete regions of the second coating.
14. The wearable fluid delivery device of claim 11 , wherein the second and fourth coatings overlap.
15. The wearable fluid delivery device of claim 11 , wherein the second and fourth coatings are non-overlapping.
16. The wearable fluid delivery device of claim 11 , wherein the fourth coating is disposed in a concentration gradient throughout the second coating.
17. The wearable fluid delivery device of claim 1 , wherein the cannula comprises a third material mixed with the first material, the third material disposed in discrete regions of the cannula, the third material comprising at least one of the hydrophilic material, the anti-microbial material, the anti-inflammatory material, and the anti-thombogenic material, wherein the first, second, and third materials of the cannula each comprise different materials.